KR830004220A - 약리적 활성 펩티드 - Google Patents

약리적 활성 펩티드 Download PDF

Info

Publication number
KR830004220A
KR830004220A KR1019800004796A KR800004796A KR830004220A KR 830004220 A KR830004220 A KR 830004220A KR 1019800004796 A KR1019800004796 A KR 1019800004796A KR 800004796 A KR800004796 A KR 800004796A KR 830004220 A KR830004220 A KR 830004220A
Authority
KR
South Korea
Prior art keywords
hydrogen
primary
formula
pharmacologically active
alkyl
Prior art date
Application number
KR1019800004796A
Other languages
English (en)
Inventor
데이빗 게젤첸 폴
데오도르 슈만 로버트
Original Assignee
아더 알. 웨일
일라이 릴리 앤드 캄파니
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 아더 알. 웨일, 일라이 릴리 앤드 캄파니 filed Critical 아더 알. 웨일
Publication of KR830004220A publication Critical patent/KR830004220A/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0812—Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1016—Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/08—Endorphin or enkephalin; related peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

내용 없음

Description

약리적 활성 펩티드
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (1)

  1. 다음 일반식(Ⅱ)의 화합물을 적당한 탈차단제와 반응시킴을 특징으로하여 다음 일반식(Ⅰ)의 화합물 및 그의 약제학적으로 무독한 산부가염을 제조하는 방법.
    상기식에서
    L 및 D는 편광성을 나타내며,
    R1은 수소 또는 C1-C31급알킬이고,
    R2는 C1-C4일급 또는 이급알킬, 알릴, 사이클로프로필메틸, C1-C|2하이드록시알킬 또는 -(CH2)m-U-CH3(U는 -S- 또는이고, m은 1 또는 2이다)이며,
    R3는 수소, C1-C4일급 또는 이급알킬, 사이클로프로필메틸, 알릴 또는 프로파질이며,
    Z는 -CH2OR4,또는(이때 R4는 수소, 아세틸 또는 아세톡시메틸이며, R5는 C1-C3알킬이다)이며,
    R6는 수소, C1-C3일급알킬 또는 아미노차단그룹이며,
    R7는 위에 정의된 R2또는 하이드록시 보호그룹이며,
    R8은 수소 또는 하이드록시 보호그룹이며,
    Z'는 위에 정의된 Z거나 수지 지지체를 포함하는 Z의 전구체이다(단 R6,R7,R8또는 Z'중 하나는 차단된 잔기이다).
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019800004796A 1979-12-17 1980-12-16 약리적 활성 펩티드 KR830004220A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/104,529 US4265808A (en) 1979-12-17 1979-12-17 Pharmacologically active peptides
US104529 1993-08-12

Publications (1)

Publication Number Publication Date
KR830004220A true KR830004220A (ko) 1983-07-09

Family

ID=22300976

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019800004796A KR830004220A (ko) 1979-12-17 1980-12-16 약리적 활성 펩티드

Country Status (11)

Country Link
US (1) US4265808A (ko)
EP (1) EP0030845A3 (ko)
JP (1) JPS5697256A (ko)
KR (1) KR830004220A (ko)
BE (1) BE886679A (ko)
CA (1) CA1142514A (ko)
FR (1) FR2471972A1 (ko)
GB (1) GB2065133B (ko)
HU (1) HU185022B (ko)
IL (1) IL61702A (ko)
IT (1) IT1141137B (ko)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2702711A1 (de) 1976-02-02 1977-08-04 Sandoz Ag Neue organische verbindungen, ihre herstellung und verwendung
US4322340A (en) * 1980-10-20 1982-03-30 Eli Lilly And Company Pharmacologically active peptides
US4448717A (en) * 1982-11-12 1984-05-15 Eli Lilly And Company Pharmacologically active peptides
GB8314646D0 (en) * 1983-05-26 1983-06-29 Wellcome Found Pharmaceutical amides
US4495178A (en) * 1983-10-06 1985-01-22 G. D. Searle & Co. Enkephalin analogs
US5965698A (en) * 1993-04-23 1999-10-12 Virginia Commonwealth University Polypeptides that include conformation-constraining groups which flank a protein--protein interaction site
US5952465A (en) * 1993-04-23 1999-09-14 Virginia Commonwealth University Polypeptides that include conformation-constraining groups which flank a protein-protein interaction site
US6258550B1 (en) 1993-04-23 2001-07-10 Virginia Commonwealth University Polypeptides that include conformation-constraining groups which flank a protein-protein interaction site
US5928896A (en) * 1993-04-23 1999-07-27 Virginia Commonwealth University Polypeptides that include conformation-constraining groups which flank a protein--protein interaction site
WO1994025482A1 (en) * 1993-04-23 1994-11-10 Evans Herbert J Polypeptides that include conformation-constraining groups which flank a protein-protein interaction site
US6084066A (en) * 1993-10-29 2000-07-04 Virginia Commonwealth University Polypetides that include conformation-constraining groups which flank a protein-protein interaction site

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1577115A (en) * 1976-07-27 1980-10-22 Reckitt & Colmann Prod Ltd Container closure units
US4259234A (en) * 1976-09-27 1981-03-31 Eli Lilly And Company Analgesic compounds
GB2004891B (en) * 1977-09-29 1982-02-24 Reckitt & Colmann Prod Ltd Organic compounds
US4264491A (en) * 1977-10-03 1981-04-28 Eli Lilly And Company Analgesic compounds
GB2008121B (en) * 1977-10-26 1982-03-17 American Home Prod Tetrapeptides
FR2424253A1 (fr) * 1978-04-27 1979-11-23 Brun Lab Sa Le Nouveaux derives de peptides analogues des enkephalines, leur procede de preparation et leur application therapeutique

Also Published As

Publication number Publication date
FR2471972B1 (ko) 1984-07-20
JPS5697256A (en) 1981-08-05
IL61702A0 (en) 1981-01-30
EP0030845A2 (en) 1981-06-24
HU185022B (en) 1984-11-28
CA1142514A (en) 1983-03-08
FR2471972A1 (fr) 1981-06-26
IT8026674A0 (it) 1980-12-16
IL61702A (en) 1984-05-31
GB2065133B (en) 1983-06-02
IT1141137B (it) 1986-10-01
BE886679A (fr) 1981-06-16
EP0030845A3 (en) 1981-11-04
US4265808A (en) 1981-05-05
GB2065133A (en) 1981-06-24

Similar Documents

Publication Publication Date Title
US4302465B1 (ko)
KR890006599A (ko) 복소환 유도체, 그의 제법 및 이를 활성성분으로 함유하는 방사선 감응제 및 항비루스제
FI864527A (fi) Tricyklofoereningar, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska blandning.
KR840004441A (ko) 포스포리피드 유도체의 제조방법
GR69233B (ko)
KR850006938A (ko) 폴루로뮤티린 유도체의 제조방법
KR870006039A (ko) 신규 티아졸 화합물, 그 제조방법 및 이 화합물을 함유하는 약학적 조성물
KR830004220A (ko) 약리적 활성 펩티드
KR830001214A (ko) 1,2,4,5-테트라-알킬-4-아릴피페리딘
KR830004219A (ko) 약리적 활성 펩티드
KR830004218A (ko) 약리적 활성 펩티드
KR850001746A (ko) 퀴나졸린 화합물의 제조방법
KR830004217A (ko) 약학적 활성이 있는 펩타이드
KR840005426A (ko) 피리딜알킬 나이트레이트 화합물의 제조방법
KR850004470A (ko) 유기 화합물의 제조방법
KR860001815A (ko) 옥타하이드로-옥사졸로[4,5-g]퀴놀린의 제조방법
KR840006012A (ko) 포스페이트 유도체의 제조방법
ES8205219A1 (es) Un metodo para producir un compuesto de hidrouracilo
KR830001899A (ko) 4-아미노-3-퀴놀린카복실산 및 에스테르-항분비, 항궤양 화합물
GB1466411A (en) Sulphur-containing hydroxy aliphatic compounds
KR920008012A (ko) 트리아졸 유도체
ES8302734A1 (es) Procedimiento para preparar 5'-n-(aminoalquil)-amino-5'-deo-xiadenosina
KR840007010A (ko) 설타미실린 및 동족체의 제조방법
KR830007520A (ko) 펩타이드의 제조방법
KR840004099A (ko) 진통제 및 소염제 화합물 제조방법